Welcome to Evently

Lorem ipsum proin gravida nibh vel veali quetean sollic lorem quis bibendum nibh vel velit.

Evently

Stay Connected & Follow us

Simply enter your keyword and we will help you find what you need.

What are you looking for?

Write us on info@evently.com

What is
GTRD ?

The Gene Therapy Area of Major Interest (DIM Gene Therapy) launches the first edition of Gene Therapy for Rare Monogenic Diseases, an international symposium dedicated to recent knowledge and progress in the field to ensure faster and more efficacious development of therapies for diseases with high unmet medical needs. With 200 intended key actors, this two-day event is the unique opportunity to discover the latest gene therapy trends and to see emerge high-potential collaborations.

What does GTRD include ?

Conferences

Keynotes with international high-level speakers from the Europe and the US, mainly focused on clinical gene therapy

Posters

Posters on the latest gene therapy trends and technologies

Pitchs

Presentations of research activities and major achievements from the Gene Therapy Area of Major Interest initiative research teams in the larger context of the recent progress in the field

Right Parallax Background Element

Speakers

Over 20 international experts from academia, industry and biotechs will address issues to discover the latest trends and approaches in the field of gene therapy, by sharing their expertise and knowledge.

Head of Human Lymphohematopoiesis Lab

Imagine Institute

Professor of Molecular Biology at University

University of Modena and Reggio Emilia

Professor of pediatrics – Stem cell transplantation

Stanford Medicine, Department of Pediatrics

Professor of Haematology and Director

Katharine Dormandy Heamophilia Centre and Thrombosis Unit, Royal Free Hospital

Professor of Ophthalmology, University Paris VII Diderot

Ophthalmological Foundation A. de Rothschild - Bichat Hospital

Director of the Center for Gene Therapy

The Research Institute at Nationwide Children's

Director of the Hematopoietic Innovative Therapies Division

CIEMAT/ CIBERER

Director Gene Therapy Program

Dana-Farber/Boston Children’s Cancer and Blood Disorders Center

Senior Vice President & CSO

RegenX bio

Pharmacology and toxicology lead

Spark Therapeutics

Associate Clinical Director, Clinical Research Development

Bluebird Bio

Researcher in Transfusion and Pathologies of the Red Blood Cell Unit

Henri-Mondor University Hospital

Head of Unit at Scientific Institute San Raffaele

Scientific Institute San Raffael

Head of Chromatin and gene regulation during development Lab

Imagine Institute

Group Leader Biotherapeutics departement

Vision Institute

Researcher in Immunology department

Pitié-Salpètrière Hospital

Senior scientist in Integrated Biology of the Red Cell Unit

National Institute of Blood Transfusion

Researcher in Hearing Genetic and physiology unit

Pasteur Institute

Left Parallax Background Element

Sponsors